Scientists "resurrected" a pig, how far are humans from resurrecting the dead?
Release time:
2022-10-14
On August 3, 2022, the team of neurobiologist Nenad Sestan of Yale University School of Medicine in the United States published the "Sow Resurrection" experiment and its results in "Nature", which attracted widespread attention and discussion. This overturns the long-held belief that brain death is irreversible.
In this experiment, after one hour of ischemia and hypoxia, the pigs were injected with a "revival agent", which was mainly composed of a mixture of pig blood, artificial hemoglobin, nutrients needed by cells and other compounds. Over the next six hours, the researchers found that some cells in the pig's heart, liver, kidneys and brain began to restore function and activity, and the pig's circulatory system also gradually recovered. Although the pig's heart has not fully resumed beating, electrophysiological activity can be scanned. In every vital organ, cells are restarting parts of their metabolism. During the whole process, people were also surprised to observe that its head and neck began to have involuntary muscle movements.
The system used for the experiment this time is a system called OrganEx. In OrganEx perfusion solution, the ratio of hemoglobin to blood is 1:1, so that cells can receive oxygen most efficiently. In addition, antioxidants and other drugs in the perfusion solution can be used to inhibit and alleviate cell damage. Compared with targeting a single organ, the brain, the improved version is more compatible with various organs throughout the body. Cell functions were better repaired in all major organs of pigs in the OrganEx group. Cell proliferation also occurred in pig kidney cells.
This discovery solves a major problem in the field of organ transplantation - the preservation efficiency of transplanted organs, opening the door to the future of organ transplantation. This research could increase the number of organs available for transplant in the future. Recently, the "China Organ Transplant Development Report (2020)" (hereinafter referred to as the "Report") was released. From 2015 to 2020, China ranked second in the world in terms of organ donation and transplant numbers. The "Report" points out that although the number and donation rate of organ donations in China have increased compared with before, it still faces a shortage of donors like other countries in the world and cannot meet the huge demand of domestic patients.
Experts point out that if OrganEx is used clinically in the future, it will take longer for human cells to reach the point of "irrecovery", and the point at which an individual is declared dead will also change, which means that with the continuous advancement of medicine, The definition of death will continue to adjust.
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
